Sun Pharma to acquire 16.7% stake in Lyndra Therapeutics for $30 mn
According to Sun Pharma, the purpose of the strategic investment is to obtain access to the technology for certain compounds and territories while also fostering the development of novel pharmaceutical delivery systems.